美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
符合检索条件的记录共10
1 页 当前第 1 页  返回检索页
1药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号203580产品号001
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 5MG BASE;12.5MG;20MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构TORRENT PHARMACEUTICALS LTD
2药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号203580产品号002
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 5MG BASE;12.5MG;40MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构TORRENT PHARMACEUTICALS LTD
3药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号203580产品号003
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 5MG BASE;25MG;40MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构TORRENT PHARMACEUTICALS LTD
4药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号203580产品号004
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 10MG BASE;12.5MG;40MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构TORRENT PHARMACEUTICALS LTD
5药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号203580产品号005
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 10MG BASE;25MG;40MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构TORRENT PHARMACEUTICALS LTD
6药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号206137产品号001
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 5MG BASE;12.5MG;20MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构PAR PHARMACEUTICAL INC
7药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号206137产品号002
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 5MG BASE;12.5MG;40MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构PAR PHARMACEUTICAL INC
8药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号206137产品号003
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 5MG BASE;25MG;40MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构PAR PHARMACEUTICAL INC
9药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号206137产品号004
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 10MG BASE;12.5MG;40MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构PAR PHARMACEUTICAL INC
10药品名称OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
申请号206137产品号005
活性成分AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 10MG BASE;25MG;40MG
治疗等效代码AB参比药物
批准日期2016/10/26申请机构PAR PHARMACEUTICAL INC